Final Prospectus Details Resale of 200 Million Shares, Confirming Massive Dilution for Nano-Cap IVPR

summarizeSummary

Inspire Veterinary Partners filed a final prospectus for the resale of up to 200 million Class A common shares by a selling stockholder, representing over 200% dilution for the recently delisted, financially distressed company.

check_boxKey Events

• Finalizes Terms for Massive Share Resale

  This 424B3 filing finalizes the terms for the resale of up to 200,000,000 Class A common shares by a selling stockholder, Manetto Hill Fund Series I, LLC. This follows the S-1/A registration statement filed on January 28, 2026.

• Extreme Potential Dilution

  The 200 million shares represent a potential dilution of over 200% compared to the 92,249,980 Class A common shares outstanding as of December 31, 2025.

• Deep Discount Conversion Price

  The shares are issuable upon conversion of secured convertible notes at a price equal to the lesser of $0.06 per share or 80% of the lowest traded price during the prior 15 trading days, subject to a floor price of $0.01 per share. With the current stock price at $0.0064, conversions will occur at the $0.01 floor.

• No Direct Proceeds to Company from Resale

  The company will not receive any proceeds from the sale of these shares by the selling stockholder, though the underlying notes provided capital to the company.

auto_awesomeAnalysis

This 424B3 filing finalizes the terms for the resale of up to 200 million Class A common shares by a selling stockholder, confirming a massive dilutive event for Inspire Veterinary Partners. The shares, stemming from secured convertible promissory notes, represent over 200% of the company's currently outstanding Class A common stock. The conversion price floor of $0.01 per share, while above the current market price of $0.0064, still reflects a deep discount and will lead to substantial dilution. This event exacerbates the company's precarious financial position, highlighted by its recent delisting from Nasdaq and ongoing 'going concern' issues. The potential influx of these shares into the market creates a significant overhang and could further depress the stock price, severely impacting existing shareholders.